- Home
- CURV vs CGTX Comparison
CURV vs CGTX Comparison
Compare CURV & CGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CURV | CGTX |
|---|---|---|
| Founded | 2001 | 2007 |
| Country | United States | United States |
| Employees | 7590 | N/A |
| Industry | Clothing/Shoe/Accessory Stores | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 122.0M | 132.4M |
| IPO Year | 2021 | 2021 |
Fundamental Metrics
Financial Performance| Metric | CURV | CGTX |
|---|---|---|
| Price | $1.24 | $1.47 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 6 | 3 |
| Target Price | $1.59 | ★ $3.33 |
| AVG Volume (30 Days) | 374.4K | ★ 938.8K |
| Earning Date | 12-03-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $1,039,486,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.94 | $0.22 |
| 52 Week High | $7.19 | $3.83 |
Technical Indicators
Market Signals| Indicator | CURV | CGTX |
|---|---|---|
| Relative Strength Index (RSI) | 56.68 | 49.06 |
| Support Level | $1.03 | $1.37 |
| Resistance Level | $1.35 | $1.50 |
| Average True Range (ATR) | 0.10 | 0.09 |
| MACD | 0.03 | 0.01 |
| Stochastic Oscillator | 70.82 | 56.25 |
Price Performance
Historical ComparisonAbout CURV Torrid Holdings Inc.
Torrid Holdings Inc is a direct-to-consumer brand of apparel, intimates, and accessories in North America. The company is focused on fit and offers high-quality products across a broad assortment that includes tops, bottoms, denim, dresses, intimates, activewear, footwear, and accessories. The company has one reportable segment, which includes the operation of the e-commerce platform and stores. The company generates revenue from the sale of apparel, intimates, and accessories through its e-commerce platform and its store locations.
About CGTX Cognition Therapeutics Inc.
Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of, small-molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its product candidate CT1812, is an orally delivered, small-molecule antagonist designed to penetrate the blood-brain barrier and bind selectively to the S2R complex.